These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21311221)

  • 1. The transcription factor FOXM1c binds to and transactivates the promoter of the tumor suppressor gene E-cadherin.
    Wierstra I
    Cell Cycle; 2011 Mar; 10(5):760-6. PubMed ID: 21311221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
    Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
    Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2.
    Wierstra I; Alves J
    FEBS J; 2006 Oct; 273(20):4645-67. PubMed ID: 16965535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.
    Li SK; Smith DK; Leung WY; Cheung AM; Lam EW; Dimri GP; Yao KM
    J Biol Chem; 2008 Jun; 283(24):16545-53. PubMed ID: 18408007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c.
    Ma RY; Tong TH; Cheung AM; Tsang AC; Leung WY; Yao KM
    J Cell Sci; 2005 Feb; 118(Pt 4):795-806. PubMed ID: 15671063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
    Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
    Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central domain of transcription factor FOXM1c directly interacts with itself in vivo and switches from an essential to an inhibitory domain depending on the FOXM1c binding site.
    Wierstra I; Alves J
    Biol Chem; 2007 Aug; 388(8):805-18. PubMed ID: 17655499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1, a typical proliferation-associated transcription factor.
    Wierstra I; Alves J
    Biol Chem; 2007 Dec; 388(12):1257-74. PubMed ID: 18020943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1c and Sp1 transactivate the P1 and P2 promoters of human c-myc synergistically.
    Wierstra I; Alves J
    Biochem Biophys Res Commun; 2007 Jan; 352(1):61-8. PubMed ID: 17141659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
    Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
    Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin E/Cdk2, P/CAF, and E1A regulate the transactivation of the c-myc promoter by FOXM1.
    Wierstra I; Alves J
    Biochem Biophys Res Commun; 2008 Mar; 368(1):107-15. PubMed ID: 18206647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1.
    Jin L; Datta PK
    Cell Cycle; 2014; 13(24):3909-20. PubMed ID: 25483064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4.
    Wierstra I; Alves J
    Biol Chem; 2006 Jul; 387(7):949-62. PubMed ID: 16913845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.
    Wierstra I
    Adv Cancer Res; 2013; 118():97-398. PubMed ID: 23768511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
    J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
    Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
    J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1/Cdk4 increases the transcriptional activity of FOXM1c without phosphorylating FOXM1c.
    Wierstra I
    Biochem Biophys Res Commun; 2013 Feb; 431(4):753-9. PubMed ID: 23333330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.